A peptide derived from SARS‐CoV‐2 nucleocapsid protein with broad‐spectrum anti‐coronavirus activity.

MLA

Ye, Guoguo, et al. “A Peptide Derived from SARS‐CoV‐2 Nucleocapsid Protein with Broad‐spectrum Anti‐coronavirus Activity.” Journal of Medical Virology, vol. 96, no. 4, Apr. 2024, pp. 1–5. EBSCOhost, https://doi.org/10.1002/jmv.29492.

APA

Ye, G., Tang, Y., Yang, Q., Zhang, C., Shi, H., Wang, J., Hu, X., Wan, X., Xu, Z., Liang, J., Yang, Y., Yang, M., & Liu, Y. (2024). A peptide derived from SARS‐CoV‐2 nucleocapsid protein with broad‐spectrum anti‐coronavirus activity. Journal of Medical Virology, 96(4), 1–5. https://doi.org/10.1002/jmv.29492

Chicago

Ye, Guoguo, Yimin Tang, Qin Yang, Chenhui Zhang, Huiping Shi, Jun Wang, Xiao Hu, et al. 2024. “A Peptide Derived from SARS‐CoV‐2 Nucleocapsid Protein with Broad‐spectrum Anti‐coronavirus Activity.” Journal of Medical Virology 96 (4): 1–5. doi:10.1002/jmv.29492.